Heartbeam Inc
Health Care · USD
Price
$1.145
Cap
$47M
Earnings
0/4 beat
30d Trend
+0%
Near 52-week lows — potential value or falling knife
Target range: $4 – $8 (consensus: $5.61)
Consensus: Strong Buy
Earnings history
Q4 2025
MISS
-0.14 vs -0.13
Q1 2025
MISS
-0.18 vs -0.16
Q4 2024
MISS
-0.73 vs -0.17
Q3 2024
MISS
-0.19 vs -0.15
Key macro factors
Central Banks shifting to 'Higher for Longer' interest rates could increase HeartBeam's borrowing costs and reduce investor appetite for growth-oriented medical technology companies that are not yet profitable.
Elevated US inflation (3.3%), partly due to geopolitical events, may lead to higher operational expenses for HeartBeam, impacting its research and development, manufacturing, and administrative costs.
Oil price volatility, stemming from global supply chain disruptions like the Strait of Hormuz closure, could indirectly affect HeartBeam by increasing transportation and raw material costs for its medical devices.
HeartBeam, Inc. is a medical technology company focused on transforming cardiac care by providing powerful personalized insights through cable-free, credit card-sized ECG devices for the detection and monitoring of critical cardiac conditions outside a healthcare facility setting.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.